Titan Pharmaceuticals Inc./$TTNP
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Ticker
$TTNP
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
4
ISIN
US8883147055
Website
TTNP Metrics
BasicAdvanced
$5.2M
-
-$4.60
1.31
-
Price and volume
Market cap
$5.2M
Beta
1.31
52-week high
$5.76
52-week low
$3.20
Average daily volume
46K
Financial strength
Current ratio
7.728
Quick ratio
7.262
Profitability
EBITDA (TTM)
-4.024
Management effectiveness
Return on assets (TTM)
-57.20%
Return on equity (TTM)
-105.70%
Valuation
Price to book
2.14
Price to tangible book (TTM)
2.14
Price to free cash flow (TTM)
-0.973
Free cash flow yield (TTM)
-102.77%
Free cash flow per share (TTM)
-452.17%
Growth
Earnings per share change (TTM)
-27.75%
3-year earnings per share growth (CAGR)
-35.65%
TTNP News
AllArticlesVideos
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
GlobeNewsWire·3 days ago
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
GlobeNewsWire·4 weeks ago
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Titan Pharmaceuticals Inc. stock?
Titan Pharmaceuticals Inc. (TTNP) has a market cap of $5.2M as of June 30, 2025.
What is the P/E ratio for Titan Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for Titan Pharmaceuticals Inc. (TTNP) stock is 0 as of June 30, 2025.
Does Titan Pharmaceuticals Inc. stock pay dividends?
No, Titan Pharmaceuticals Inc. (TTNP) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Titan Pharmaceuticals Inc. dividend payment date?
Titan Pharmaceuticals Inc. (TTNP) stock does not pay dividends to its shareholders.
What is the beta indicator for Titan Pharmaceuticals Inc.?
Titan Pharmaceuticals Inc. (TTNP) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.